{"title":"A generic version of a drug that&#8217;s &#8220;as close as we&#8217;ve ever...","link":"https://kottke.org/24/07/0044995-a-generic-version-of-a","date":1721753994000,"content":"\n        A generic version of a drug thatâ€™s â€œas close as weâ€™ve ever been to an HIV vaccineâ€ <a href=\"https://www.theguardian.com/global-development/article/2024/jul/23/hiv-aids-prevention-vaccine-lenacapavir-sunlenca-pharmaceuticals-gilead-generic-licensing\">could be made for $40 a year per patient (with a 30% profit)</a>. Current pricing by Gilead: $42,250 per year.\n\n        \n\n        \n\n         <p>ğŸ’¬ <a href=\"https://kottke.org/24/07/0044995-a-generic-version-of-a\">Join the discussion on kottke.org</a> â†’</p>\n\n    ","author":"Jason Kottke","siteTitle":"Kottke","siteHash":"89a883271b4598f9b33ebe87be70d38557bcd266e68aee521a8f93622e0ab723","entryHash":"911136d961ecbf41e047c9b8f258a7e740d60eb892bbff1d863447b15ab08458","category":"default"}